Streamlined electronic access now available for Natera’s clinical oncology portfolio across Flatiron Health’s network of 4,500+ cancer care providers
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, and Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point-of-care solutions in oncology, today announced the integration of Natera’s oncology testing portfolio into OncoEMR®, Flatiron’s cloud-based Electronic Medical Record (EMR) platform. The integration enables seamless electronic ordering and results delivery for Natera’s oncology tests directly within the clinical workflow of thousands of U.S. cancer care providers.
The two-way integration provides oncologists with a unified ordering experience for Signatera™ and all of Natera’s oncology offerings, built directly into the EMR system. Once processed, test results are returned electronically to the ordering provider within the OncoEMR interface, ensuring timely access to actionable insights. This creates a seamless experience for over 4,500 providers and 1,000 community-based care locations nationwide, making it even easier to incorporate molecular residual disease (MRD) testing and monitoring into routine care.
“We aim to equip providers with smart, connected tools that enhance care delivery without adding complexity,” said Quincy Weatherspoon, vice president and general manager of point of care solutions at Flatiron Health. “Natera is a leader in precision medicine, and integrating the company’s oncology testing into OncoEMR exemplifies how thoughtful technology can drive efficiency at scale, support our provider networks and clinicians, and improve patient care and outcomes.”
“Clinicians need testing solutions that are both scientifically rigorous and operationally seamless,” said Minetta Liu, M.D., chief medical officer of oncology at Natera. “This integration was designed with their daily workflows in mind—reducing administrative steps and accelerating access to molecular insights that can be used to guide confident treatment decisions.”
Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!